CareDx (CDNA) Tops Q3 EPS by 39c, Beats on Revenue; Offers FY24 Revenue Guidance

CareDx (NASDAQ: CDNA) reported Q3 EPS of $0.14, $0.39 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $82.9 million versus the consensus estimate of $79.69 million.

GUIDANCE:

CareDx sees FY2024 revenue of $327-331 million, versus the consensus of $326 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• A. O. Smith CEO Stephen Shafer named chairman